Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
ACT I
Carotid Stenting vs. Surgery of Severe Carotid Artery Disease and Stroke Prevention in Asymptomatic Patients



Principal Investigator
Jon Matsumura, MD & Kenneth Rosenfield, MD

PI Address
1st P.I.
Jon Matsumura, MD
University of Wisconsin
2nd Principal Investigator: Kenneth Rosenfield, MD
Massachusetts General Hospital

Contact Address
Sandy Lee,CCRA
Direct #: 408-845-0516

Sponsor



Trial Phase:Phase III
Study Size Actual:980
Study Size Planned:1658
Centers Actual:52
Centers Planned:50
Max Time from onset:24 Hours
Max Age:79
Min Age:18
Follow-up Duration:5 Years
ISRCTN#NCT00106938
Status:
Ongoing.

Purpose:
To demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield Embolic Protection System and Emboshield Pro Embolic Protection System with the Xact Carotid Stent System to carotid endarterectomy (CEA) for the treatment of asymptomatic extracranial carotid atherosclerotic disease.

Interventions:
Carotid artery stenting with filter
Indicated for use as a guidewire and embolic protection system to contain and remove embolic material while performing angioplasty and stenting procedures in carotid arteries.
Endarterectomy, carotid
Surgical therapy to remove atherosclerotic plaque in narrowed carotid arteries.

Location(s):
USA

Year Started: 2005
Year Presented: 2010

Design:
Interventional, Other, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study.

Inclusion Criteria
Severe carotid artery disease; patients who have not had symptoms related to their carotid artery disease in the last 180 days; patients who are able to undergo either an interventional stenting or surgical procedure.

Exclusion Criteria
Patients who have had symptoms in the last 180 days; patients who are high risk for surgery; patients who have certain conditions that might confound the results of the study.

Patient Involvement:
Patients will be randomized to either an interventional treatment using a carotid artery stent and filter or the surgical procedure of carotid endarterectomy, on a 3:1 basis. This means that three interventional procedures will be conducted to each surgical (CEA) one, on average, for every four patients.

Primary Outcome:
Occurrence of major adverse events 30 days following the procedure; occurrence of ipsilateral strokes between 31 and 365 days post procedure.


Secondary Outcome:
Acute device success; procedural success; composite morbidity at 0 - 30 days post-procedure.


Comments:
Publishing Title: Asymptomatic Carotid Trial 1 (ACT 1)
Author Block: Seemant Chaturvedi, Wayne State Univ, Detroit, MI; Lawrence Wechsler, Univ of Pittsburgh, Pittsburgh, PA; for the ACT I Executive Committee

Source of Information:
Correspondence from trial sponsor [August 2005].
ClinicalTrial.gov
Abstract from 2008 ISC.
Presented at the 2008 International Stroke Conference (February 2008).
Presented at the 2010 International Stroke Conference (February 2010).

Web Links and Publications:
ISC 2010 abstract
AHA

ACT 1

ACT-1
ClinicalTrials.gov

This information last updated on: 3/9/2010

Reviewed on: 03/09/2010.

UID: 835

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2010 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, March 12, 2010